The global Real Time Polymerase Chain Reaction (qPCR) market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% over the forecast period, according to the latest report by Reports and Data.
The global Real Time Polymerase Chain Reaction (qPCR) market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% over the forecast period, according to the latest report by Reports and Data. Increasing adoption of qPCR in medical diagnosis and new product launches are key factors driving market revenue growth. In addition, rising cases of chronic diseases, such as cancer, hepatitis, Human Immunodeficiency Virus (HIV), and many others, are also driving market revenue growth. For instance, according to World Health Organization (WHO), an estimated 354 million people living worldwide live with hepatitis C or hepatitis B. By 2030, hepatitis-related premature deaths in low- and middle-income countries might be reduced by an estimated 4.5 million owing to treatment kits such as qPCR, medications, and others.
Recent technological advancements, investments in research, and launch of new products are other factors driving qPCR market revenue growth. For instance, on 27 October 2021, Azure Biosystems, a provider of innovative bioanalytical solutions for protein and cell biology announced to distribute Azure Cielo Dx in European Union (EU) for In Vitro Diagnostic (IVD) use. Azure Cielo 3 Dx and Azure Cielo 6 Dx are real-time PCR systems that adhere to EU’s In Vitro Diagnostic Directive (IVDD) for 3 and 6-channel nucleic acid detection respectively. A 10.3" touch screen interface with simple software makes it simple to start up, which runs and checks if run status controls the instrument. In addition, small device supports data transfer over USB, ethernet, and Wi-Fi. The system includes Azure Cielo Manager software, which provides a full workflow solution for real-time PCR run setup and data processing.
Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/5500
Some Key Highlights From the Report
-
- On 9 November 2020, Streck, headquartered in the U.S., which develops and manufactures products in hematology, immunology, molecular diagnostics, cell stabilization, infectious diseases, and urinalysis for clinical and research laboratories announced to launch Zulu RT, which is a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can complete a 40-cycle, 6-channel, 3-step real-time PCR in less than 20 minutes. In addition, Zulu RT combines exclusive, proprietary thermal technology from Streck with potent optics. Moreover, it can do rapid, six-color detection faster than any other conventional instrument and has excellent thermal management.
- The reagents and consumables segment accounted for largest revenue share in 2021. This is due to affordability of core kits when compared to master mixes, freedom to design customized reaction protocols, expansion of private and public funding for life science research, and expansion of market accessibility of qPCR kits in developed countries.
- The blood and oncology segment accounted for largest revenue share in 2021 due to increasing adoption of infectious and genetic disorders such as hepatitis, HIV, and cancer. According to HIV.gov, In 2021, 85% of all HIV-positive individuals knew that they have HIV. HIV testing is a key entry point for HIV prevention, care, treatment, and support services.
- The North America market accounted for largest revenue share in 2021. Increasing investments in healthcare and launch of new products are major factors driving market revenue growth. The U.S. is expected to lead regional demand owing to the presence of market participants such as Abbott, Thermo Fisher Scientific, Agilent Technologies, and many others. In addition, increased penetration of qPCR in diagnosing infectious diseases, such as HIV, malaria, and others, is driving market revenue growth.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/5500
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, F. Hoffman-La Roche Ltd, BD, Agilent Technologies Inc., Integrated DNA Technologies Inc., Standard BioTools, Takara Bio Inc., and Lumex Instruments.
Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/real-time-polymerase-chain-reaction-qpcr-market
Real Time Polymerase Chain Reaction (qPCR) Market Segmentation:
Product Type Outlook (Revenue, USD Billion; 2019–2030)
- Reagents and Consumables
- Instruments
- Software and Services
Application Outlook (Revenue, USD Billion; 2019–2030)
- Blood and Oncology Testing
- Pathogen Testing
- Research and Development
- Forensic Testing
- Others
End-Use Outlook (Revenue, USD Billion; 2019–2030)
- Hospitals
- Research Laboratories and Academic Institutes
- Diagnostic Centers
- Clinical Research Organizations (CROs)
- Forensic Laboratories
- Pharma and Biotech Companies
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/5500
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore More Industry Research by Reports and Data:
Amoxicillin Market Analysis, By Infection Type, Route (Oral, Intravenous), Form (Tablets, Capsule, Suspensions, Syrup, Powder), Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others), And By Region, And Segment Forecasts To 2028 - Download PDF Brochure
Cardiomyopathy Medication Market Analysis, By Disease, Product (Anticoagulants, Antiarrhythmics, Anti-Hypertensives, Cardiac Glycosides, Others), End User (Hospitals and Clinics, Ambulatory Service Centers, Others), Region, Forecasts to 2028 - Download PDF Brochure
Leishmaniasis Treatment Market Analysis, By Disease Type (Cutaneous Leishmaniasis, Mucosal Leishmaniasis, and Visceral Leishmaniasis), By Pathological Tests (Serological Tests, Parasitological Evaluation), By Therapy Type (Drug Therapy, Non-Drug Therapy), By End User (Hospitals, Clinics, Diagnostic Laboratories), Forecast to 2028 - Download PDF Brochure
Point of Care Hemoglobin Analyzer Market Analysis, by Method (Invasive, and Non- Invasive methods), Application (Diabetes diagnosis, Anemia diagnosis, and Others), by End Use (Hospitals, Personal Use, Diagnostic Centers and Others), Forecasts to 2028 - Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos